MT-2221

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMT-2221
Drug Alias NameMT-2221
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIshihara Sangyo Kaisha
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIshihara Sangyo Kaisha
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A